Rendering

Component: (Network and Table)
Network
100340 - Disclosure - Equity (Tables)
(http://www.aptevotherapeutics.com/20161231/taxonomy/role/DisclosureEquityTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001671584 (http://www.sec.gov/CIK)
Equity [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Equity [Abstract]
 
Summary of Stock-based Compensation Expense Includes Amortization of Stock Options and Restricted Stock Units Granted

Stock-based compensation expense includes amortization of stock options and restricted stock units granted to employees and non-employees and has been reported in our Consolidated Statements of Operation and Comprehensive Loss as follows:

 

(in thousands)

 

December 31, 2016

December 31, 2015

 

Research and development

 

$

2,693

 

 

$

1,107

 

General and administrative

 

 

1,116

 

 

 

—

 

Total stock-based compensation expense

 

$

3,809

 

 

$

1,107

 

 

  
Assumptions used in Valuing the Stock Options Granted under Black-Scholes Valuation Model

Aptevo utilizes the Black-Scholes valuation model for estimating the fair value of all stock options granted. Set forth below are the assumptions used in valuing the stock options granted:

 

 

 

December 31, 2016

 

Expected dividend yield

 

 

0.00%

 

Expected volatility

 

 

75.00%

 

Risk-free interest rate

 

 

1.23%

 

Expected average life of options

 

6 years

 

 

  
Summary of Stock Option Activity

The following is a summary of option activity for the year ended December 31, 2016:

 

 

 

Number of

Shares

 

 

Weighted-

Average

Exercise Price

 

 

Weighted-

Average

Remaining Term

 

 

Aggregate

Intrinsic

Value

 

Outstanding Aptevo Options at December 31, 2015

 

 

—

 

 

$

—

 

 

 

 

 

 

$

—

 

Aggregate impact of conversion related to spin-off

 

 

1,672,177

 

 

 

2.49

 

 

 

 

 

 

 

127,520

 

Granted

 

 

456,075

 

 

 

2.83

 

 

 

 

 

 

 

35,306

 

Exercised

 

 

(9,144

)

 

 

2.15

 

 

 

 

 

 

 

(8,839

)

Forfeited

 

 

(33,894

)

 

 

2.48

 

 

 

 

 

 

 

(5,369

)

Outstanding at December 31, 2016

 

 

2,085,214

 

 

$

2.57

 

 

 

6.20

 

 

$

153,987

 

Exercisable at December 31, 2016

 

 

514,045

 

 

$

2.25

 

 

 

4.30

 

 

$

119,169

 

 

  
Summary of Restricted Stock Activity

The following is a summary of restricted stock activity for the year ended December 31, 2016:

 

 

 

Number of

Units

 

 

Weighted

Average Fair

Value per Unit

 

 

Aggregate

Fair Value

 

Outstanding Aptevo RSU's at December 31, 2015

 

 

—

 

 

$

—

 

 

$

—

 

Aggregate impact of conversion related to spin-off

 

 

1,223,215

 

 

 

2.76

 

 

 

—

 

Granted

 

 

2,115,772

 

 

 

2.94

 

 

 

—

 

Converted

 

 

(140,882

)

 

 

2.42

 

 

 

—

 

Forfeited

 

 

(163,910

)

 

 

2.90

 

 

 

—

 

Outstanding at December 31, 2016

 

 

3,034,195

 

 

$

2.88

 

 

$

7,403,435

 

Expected to Vest

 

 

2,801,201

 

 

$

2.88

 

 

$

6,834,930